David Lebowitz

Q: What is David Lebowitz's success rate?

David Lebowitz currently has a success rate of 83.94276583755413.

Q: What is the average return of David Lebowitz's calls?

Their stock ratings have generated an average return of 25.96079096125809.

BMO Capital | Healthcare

David Lebowitz is an analyst from BMO Capital specializing in the Healthcare sector. Ranked #1005 out of 4754 analysts, they have issued 10 stock ratings with a success rate of 83.94% and an average return of 25.96%.

With 10 ratings to date, David Lebowitz is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 83.94% and an average return of 25.96%, highlighting promising potential as their track record develops further.

#1005

Out of 4754

Total Ratings

+83.94%

Success Rate

+25.96%

Average Return

Recent Ratings Analysis

BMRN

Buy

Aug 19, 2026

Target

$98.00

Current

$69.33

Performance

0.00%

David Lebowitz rated BMRN as Outperform on Aug 19, 2026, setting a price target of 98. Shares have remained stable near 69.33, leaving the 98 target still in play.

ALNY

Buy

Aug 19, 2026

Target

$318.00

Current

$242.61

Performance

0.00%

On Aug 19, 2026, ALNY was given a Outperform rating by David Lebowitz, with a target price of 318. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

CATX

Buy

Aug 19, 2026

Target

$11.00

Current

$3.48

Performance

0.00%

CATX received a Outperform rating from David Lebowitz on Aug 19, 2026, aiming for 11. Price action was muted, as shares hovered around 3.48 despite the bullish outlook.

AKTS

Buy

Aug 19, 2026

Target

$37.00

Current

$25.02

Performance

0.00%

On Aug 19, 2026, David Lebowitz published a Outperform outlook on AKTS, with a target of 37. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 25.02.

BCAX

Buy

Aug 19, 2026

Target

$35.00

Current

$25.86

Performance

0.00%

David Lebowitz on Aug 19, 2026 assigned BCAX a Outperform rating, with a price target of 35. The recommendation remains pending validation as shares consolidate around 25.86.

ASND

Buy

Aug 19, 2026

Target

$319.00

Current

$259.62

Performance

0.00%

On Aug 19, 2026, David Lebowitz reaffirmed ASND with a Outperform rating, targeting 319. Market indecision has kept the 319 target in a holding pattern.

IONS

Buy

Sep 03, 2025

Target

$84.00

Current

$60.80

Performance

0.51%

IONS was rated Buy by David Lebowitz on Sep 03, 2025, with a price objective of 84. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

CYTK

Buy

Sep 02, 2025

Target

$84.00

Current

$77.74

Performance

56.67%

On Sep 02, 2025, David Lebowitz initiated coverage on CYTK with a Buy rating and target of 84. The stock’s climb of 56.67% since the call highlights the foresight in the rating.

CLDX

Buy

Aug 20, 2025

Target

$48.00

Current

$41.70

Performance

99.62%

David Lebowitz issued a Buy recommendation for CLDX on Aug 20, 2025, price target set at 48. Investors following the Buy call captured upside momentum, with shares now at 41.7.

SDGR

Hold

Aug 15, 2025

Target

$20.00

Current

$19.85

Performance

2.43%

On Aug 15, 2025, SDGR was evaluated by David Lebowitz, who gave a Neutral rating and target of 20. Hold sentiment was validated by subdued trading with no breakout beyond 19.85.

INCY

Buy

Jul 30, 2025

Target

$103.00

Current

$128.47

Performance

65.66%

David Lebowitz rated INCY as Buy on Jul 30, 2025, setting a price target of 103. The call has proven timely, with shares rising 65.66% toward the price target of 103.

VKTX

Hold

Jul 24, 2025

Target

$38.00

Current

$35.98

Performance

7.40%

On Jul 24, 2025, VKTX was given a Neutral rating by David Lebowitz, with a target price of 38. The stock rallied from 35.98 to 35.98 after the Hold rating, surprising to the upside.

COGT

Buy

Jul 18, 2025

Target

$22.00

Current

$36.85

Performance

195.04%

COGT received a Buy rating from David Lebowitz on Jul 18, 2025, aiming for 22. Momentum has favored the Buy call, with shares climbing from 36.85 to 36.85, rewarding those who trusted the recommendation.

BBIO

Buy

Jul 11, 2025

Target

$67.00

Current

$83.95

Performance

80.65%

On Jul 11, 2025, David Lebowitz published a Buy outlook on BBIO, with a target of 67. Shares gained 80.65%, underscoring the accuracy of the bullish outlook toward 67.

PLRX

Hold

Mar 04, 2025

Target

$1.50

Current

$1.17

Performance

-13.33%

David Lebowitz on Mar 04, 2025 assigned PLRX a Neutral rating, with a price target of 1.5. The call successfully avoided chasing as shares lost 13.33%.

NTLA

Hold

Feb 28, 2025

Target

$14.00

Current

$13.28

Performance

31.62%

On Feb 28, 2025, David Lebowitz reaffirmed NTLA with a Neutral rating, targeting 14. Market strength beyond 13.28 went further than the conservative outlook suggested.

PTCT

Sell

Feb 12, 2025

Target

$45.00

Current

$73.67

Performance

50.56%

PTCT was rated Sell by David Lebowitz on Feb 12, 2025, with a price objective of 45. Bearish sentiment was justified as the stock retreated to 73.67.

EXEL

Buy

Feb 12, 2025

Target

$45.00

Current

$54.39

Performance

65.82%

On Feb 12, 2025, David Lebowitz initiated coverage on EXEL with a Buy rating and target of 45. The stock’s climb of 65.82% since the call highlights the foresight in the rating.

MIRM

Buy

Jun 18, 2024

Target

$64.00

Current

$102.24

Performance

249.54%

David Lebowitz issued a Buy recommendation for MIRM on Jun 18, 2024, price target set at 64. Investors following the Buy call captured upside momentum, with shares now at 102.24.

BPMC

Sell

May 03, 2024

Target

$76.00

Current

$129.46

Performance

20.78%

On May 03, 2024, BPMC was evaluated by David Lebowitz, who gave a Sell rating and target of 76. Investors benefited from heeding the Sell stance, avoiding a 20.78% decline.

Frequency Asked Questions

Who is David Lebowitz?

David Lebowitz is an analyst from BMO Capital specializing in the Healthcare sector.

What is David Lebowitz's success rate?

David Lebowitz currently has a success rate of +83.94%.

How many ratings has David Lebowitz issued?

David Lebowitz has issued 10 stock ratings so far.

What is the average return of David Lebowitz's calls?

Their stock ratings have generated an average return of +25.96%.

What is David Lebowitz's ranking?

David Lebowitz is ranked #1005 out of 4754 analysts.

What types of ratings does David Lebowitz give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Lebowitz?

You can follow David Lebowitz by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Lebowitz?

Their latest rating was a Buy on BMRN issued on 2026-08-19.